Minerva Advisors LLC Sells 35,728 Shares of Kewaunee Scientific Corporation (NASDAQ:KEQU)

Key Points

• Minerva Advisors LLC has reduced its stake in Kewaunee Scientific Corporation by 32.6%, now owning 73,765 shares, while the stock represents 1.8% of their investment portfolio.
• Bank of America Corp DE and IFP Advisors Inc significantly increased their holdings in Kewaunee Scientific, indicating a strong interest from institutional investors.
• Kewaunee Scientific stock is currently valued at $55.34, down 1.4%, and has a market cap of $163.25 million with a PE ratio of 14.45.

Minerva Advisors LLC decreased its position in shares of Kewaunee Scientific Corporation (NASDAQ:KEQU - Free Report) by 32.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 73,765 shares of the technology company's stock after selling 35,728 shares during the quarter. Kewaunee Scientific makes up about 1.8% of Minerva Advisors LLC's portfolio, making the stock its 16th biggest holding. Minerva Advisors LLC owned approximately 2.58% of Kewaunee Scientific worth $2,905,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. IFP Advisors Inc increased its stake in Kewaunee Scientific by 61.5% in the first quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock valued at $37,000 after purchasing an additional 360 shares during the last quarter. Bank of America Corp DE lifted its holdings in Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after acquiring an additional 443 shares during the period. O Shaughnessy Asset Management LLC increased its position in shares of Kewaunee Scientific by 3.3% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company's stock valued at $1,733,000 after buying an additional 891 shares in the last quarter. Wedbush Securities Inc. acquired a new stake in shares of Kewaunee Scientific during the 4th quarter worth about $262,000. Finally, Jane Street Group LLC purchased a new stake in Kewaunee Scientific in the 4th quarter valued at about $300,000. Institutional investors and hedge funds own 32.69% of the company's stock.

Kewaunee Scientific Price Performance

Shares of Kewaunee Scientific stock traded down $0.40 during trading on Monday, hitting $54.38. The stock had a trading volume of 3,572 shares, compared to its average volume of 19,092. The company has a debt-to-equity ratio of 0.92, a current ratio of 2.20 and a quick ratio of 1.59. The firm has a market cap of $160.42 million, a P/E ratio of 14.20 and a beta of 0.70. The business has a fifty day moving average of $48.82 and a two-hundred day moving average of $47.26. Kewaunee Scientific Corporation has a fifty-two week low of $30.33 and a fifty-two week high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its quarterly earnings data on Wednesday, June 25th. The technology company reported $1.95 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 26.02% and a net margin of 4.74%. The firm had revenue of $77.15 million during the quarter.

Insider Activity at Kewaunee Scientific

In other Kewaunee Scientific news, CFO Donald T. Gardner III sold 3,000 shares of the firm's stock in a transaction that occurred on Thursday, July 24th. The stock was sold at an average price of $58.59, for a total value of $175,770.00. Following the completion of the sale, the chief financial officer owned 14,564 shares in the company, valued at approximately $853,304.76. This trade represents a 17.08% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 13.30% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen raised Kewaunee Scientific from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.